Published in BMJ on March 21, 1998
Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service. Arch Dis Child (2000) 0.99
Repeat whole cell vaccinations should be avoided after hypotonic-hyporesponsive episodes. BMJ (1998) 0.81
Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis. BMC Microbiol (2009) 0.78
Collapse reactions after whole cell pertussis vaccination. BMJ (1998) 0.75
Active surveillance study of adverse events following immunisation of children in the Czech Republic. BMC Public Health (2017) 0.75
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet (2004) 4.39
Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet (1994) 3.50
Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis (1997) 2.32
Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis (2000) 2.29
No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine (2004) 2.13
Pneumococcal vaccines: an update on current strategies. Vaccine (2004) 1.69
Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine (1996) 1.54
Light-directed synthesis of high-density oligonucleotide arrays using semiconductor photoresists. Proc Natl Acad Sci U S A (1996) 1.48
Effect of growth temperatures on the protein levels in a psychrotrophic bacterium, Pseudomonas fragi. J Bacteriol (1994) 1.39
[Osteomyelitis as a complication following BCG vaccination]. Ned Tijdschr Geneeskd (1995) 1.39
[The diphtheria epidemic in the Russian Federation and recommendations concerning diphtheria vaccination in The Netherlands]. Ned Tijdschr Geneeskd (1994) 1.39
[A measles epidemic in an adequately vaccinated middle school population]. Ned Tijdschr Geneeskd (1994) 1.39
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age. Vaccine (2000) 1.31
Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis (1995) 1.11
[Whooping cough in The Netherlands, 1989-1994]. Ned Tijdschr Geneeskd (1995) 1.03
Immunoglobulin production in human mixed lymphocyte cultures: implications for co-cultures of cells from patients and healthy donors. J Immunol (1982) 1.02
Effect of osmotic, alkaline, acid or thermal stresses on the growth and inhibition of Listeria monocytogenes. J Appl Microbiol (1999) 1.01
Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect (2001) 1.00
Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. Blood (1994) 0.96
Immunoglobulin production by human lymphocytes in a microculture system: culture conditions and cellular interactions. Clin Immunol Immunopathol (1981) 0.95
T-chronic lymphocytic leukaemia presenting as primary hypogammaglobulinaemia--evidence of a proliferation of T-suppressor cells. Clin Exp Immunol (1982) 0.95
Development of listeria monocytogenes in monoxenic and polyxenic beef minces. Zentralbl Bakteriol Orig B (1978) 0.93
Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia. J Immunol (1982) 0.92
Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands. Clin Diagn Lab Immunol (1997) 0.92
[Contraindications against vaccinations in the National Vaccination Program]. Ned Tijdschr Geneeskd (1989) 0.90
Specific nutritional requirements of Lactobacilli spp. from meat. Zentralbl Bakteriol Mikrobiol Hyg B (1986) 0.90
Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations. Vaccine (2000) 0.89
Immunisation status of children adopted from China. Lancet (2002) 0.89
Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program. Vaccine (2001) 0.88
Chronic lymphocytic leukemia. Immunologic markers and functional properties of the leukemic cells. Cancer (1982) 0.87
Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making. Vaccine (2004) 0.87
Prevention of meningococcal serogroup B infections in children: a protein-based vaccine induces immunologic memory. J Infect Dis (2001) 0.87
The cold shock response of the psychrotrophic bacterium Pseudomonas fragi involves four low-molecular-mass nucleic acid-binding proteins. J Bacteriol (1997) 0.86
Combined effects of NaCl, NaOH, and biocides (monolaurin or lauric acid) on inactivation of Listeria monocytogenes and Pseudomonas spp. J Food Prot (2001) 0.85
Blood poisonings at slaughter and their consequences. Zentralbl Bakteriol Orig B (1977) 0.84
Antibody response to Haemophilus influenzae type b vaccine in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis (1997) 0.84
Phosphinic peptide analogues as potent inhibitors of Corynebacterium rathayii bacterial collagenase. Biochem J (1994) 0.83
Isolation and partial characterization of a novel subset of human T lymphocytes defined by monoclonal antibodies. Immunology (1982) 0.83
Formation of biofilm by Staphylococcus xylosus. Int J Food Microbiol (2006) 0.82
Differential protein expression by Pseudomonas fragi submitted to various stresses. Electrophoresis (1999) 0.81
[Does a modified vaccination schedule protect better against measles?]. Ned Tijdschr Geneeskd (1994) 0.80
Dot-immunobinding assay as an accurate and versatile technique for the quantification of human IgG subclasses. J Immunol Methods (1988) 0.80
Evaluation of diphtheria convalescent patients to serve as donors for the production of anti-diphtheria immunoglobulin preparations. Vaccine (2004) 0.80
Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production. Clin Exp Immunol (1984) 0.79
[Measles in The Netherlands; epidemiology and the effect of vaccination]. Ned Tijdschr Geneeskd (1994) 0.78
[Degree of protection against poliomyelitis of Dutch subjects born before 1945 and of allochthonous subjects in Utrecht, and the relationship to socioeconomic status]. Ned Tijdschr Geneeskd (1993) 0.78
A population-based study on tetanus antitoxin levels in The Netherlands. Vaccine (1999) 0.78
[Virological and serological aspects of the Dutch polio epidemic in 1992]. Ned Tijdschr Geneeskd (1993) 0.77
Peptide inhibitors of E. collagenolyticum bacterial collagenase--effect of N-methylation. Consequences on biological activity and conformational properties. Int J Pept Protein Res (1992) 0.77
The nuclear symptom of schizophrenia and the praecoxfeeling. Hist Psychiatry (1990) 0.76
[Epidemiology of 25 years of crib death (sudden infant death syndrome) in the Netherlands; incidence of crib death and prevalence of risk factors in 1980-2004]. Ned Tijdschr Geneeskd (2005) 0.75
[Vaccination against mumps successful]. Ned Tijdschr Geneeskd (1993) 0.75
[Consensus 'Basic resuscitation' from the Nederlandse Reanimatie Raad]. Ned Tijdschr Geneeskd (1996) 0.75
[Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk]. Ned Tijdschr Geneeskd (2007) 0.75
[Purification and physico-chemical properties of collagenase synthesized by a bacterium of the type Acinetobacter sp]. Biochimie (1979) 0.75
[The nosological place of the group of schizophrenias]. Wien Z Nervenheilkd Grenzgeb (1966) 0.75
[Evaluation of the National Vaccination Program]. Ned Tijdschr Geneeskd (1989) 0.75
[Inventory of proteolytic activity of a new collagenolytic bacteria Empedobacter collagenolyticum]. Biochimie (1982) 0.75
[Induction and repression of the collagenase synthesis in Acinetobacter sp]. Can J Microbiol (1979) 0.75
[Rabies and bats: what is to be done?]. Ned Tijdschr Geneeskd (1989) 0.75
Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations. Eur J Health Econ (2004) 0.75
[Bacterial meningitis in young children. Current viewpoints in pathogenesis, treatment and prevention]. Tijdschr Kindergeneeskd (1990) 0.75
[Purification and partial characterization of an extracellular aminopeptidase of a collagenolytic bacterium: Empedobacter collagenolyticum]. Ann Microbiol (Paris) (1983) 0.75
Characterization of the inhibitory power of Lactobacillus of meat origin. Zentralbl Bakteriol B (1980) 0.75
[Haemorrhagic colitis in a young male after the use of amoxicillin]. Ned Tijdschr Geneeskd (2005) 0.75
[Teaching of medico-legal sciences at the Ecole Nationale de la Magistrature, France]. Med Leg Dommage Corpor (1974) 0.75
[Reported patients with infectious diseases in 1989]. Ned Tijdschr Geneeskd (1990) 0.75
[Hypersensitivity reactions and vaccines]. Ned Tijdschr Geneeskd (2017) 0.75
Titanium(IV) isopropoxide mediated solution phase reductive amination on an automated platform: application in the generation of urea and amide libraries. Comb Chem High Throughput Screen (2000) 0.75
[Frederik van Eeden as psychiatrist]. Ned Tijdschr Geneeskd (1986) 0.75
[Attachment of a collagenolytic strain to its substrate (author's transl)]. Ann Microbiol (Paris) (1980) 0.75
[Psychic disorders in a healthy person]. Ned Tijdschr Geneeskd (1965) 0.75
[Thoughts on exogenic non-psychotic mental disorders]. Evol Psychiatr (Paris) (1967) 0.75
Inhibition of bacterial collagenase by phosphonamide peptides. Matrix Suppl (1992) 0.75
[Rapid counting of bacteria isolated from cattle, swine and sheep carcasses using the resazurin method]. Zentralbl Bakteriol Mikrobiol Hyg B (1984) 0.75
[Purification and study of some properties of a collagenase produced by Empedobacter collagenolyticum]. Biochimie (1982) 0.75
IPV-Vero vaccine induces a strong booster reaction and is well tolerated in adults. Scand J Infect Dis (1998) 0.75
[Study of the microbial multiplication in the muscle just after slaughter (author's transl)]. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 0.75
[A better vaccine against whooping cough?]. Ned Tijdschr Geneeskd (1988) 0.75
[Effect of heating beef at 55 degrees C on the growth of Clostridium perfringens and Staphylococcus aureus]. Zentralbl Bakteriol Mikrobiol Hyg B (1984) 0.75